|
Re: June 30-July 02, 2016: 9th World Drug Delivery Summit
|
3
|
BIOASIS TECHNOLOGIES INC
|
Jul 06, 2016 08:57PM
|
|
Re: Proactive Article - new presentation on website
|
3
|
BIOASIS TECHNOLOGIES INC
|
Sep 23, 2020 08:55AM
|
|
Re: There is much more to this story
|
3
|
Resverlogix Corp.
|
Oct 01, 2019 05:02PM
|
|
Re: Don's discount
|
3
|
Resverlogix Corp.
|
Feb 04, 2018 05:09PM
|
|
Re: Finance
|
3
|
Resverlogix Corp.
|
Aug 12, 2020 04:03PM
|
|
Re: Properly powered? What does the FDA think?
|
3
|
Resverlogix Corp.
|
May 11, 2018 03:41PM
|
|
Re: Placebo or Standard of Care
|
3
|
Resverlogix Corp.
|
Nov 02, 2019 10:14AM
|
|
Re: Looking over Amarin does lead to one obvious conclusion...
|
3
|
Resverlogix Corp.
|
Feb 14, 2019 05:27PM
|
|
Re: Options
|
3
|
Resverlogix Corp.
|
Oct 22, 2019 05:15PM
|
|
Re: Secured $6M Convertable Debenture
|
3
|
Resverlogix Corp.
|
Apr 18, 2024 09:51AM
|
|
Re: Why news has to come out Thursday imo....walking in the enemy's shoes
|
3
|
Resverlogix Corp.
|
Jan 29, 2019 08:48AM
|
|
Re: RESVERLOGIX AND MEDISON PHARMA LTD. ANNOUNCE STRATEGIC LICENSING AGREEMENT
|
3
|
Resverlogix Corp.
|
Jan 08, 2018 10:39AM
|
|
Re: AACR 2018
|
3
|
Zenith Epigenetics
|
Feb 23, 2018 12:41PM
|
|
Re: Zenith Epigenetics is proud to announce the appointment Dr. Brad Thompson, PhD to our Board of Directors!
|
3
|
Zenith Epigenetics
|
Feb 10, 2022 08:31AM
|
|
Re: The leveraged play
|
3
|
Resverlogix Corp.
|
Jun 10, 2019 08:38PM
|
|
Re: Reports of Exempt Distribution
|
3
|
Zenith Epigenetics
|
Feb 09, 2023 08:30AM
|
|
Re: is anyone thinking or expecting any movement in the sp or
|
3
|
Resverlogix Corp.
|
Jan 05, 2016 06:11PM
|
|
Re: Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024
|
3
|
Zenith Epigenetics
|
Oct 15, 2024 04:23PM
|
|
Re: got filled..
|
3
|
Resverlogix Corp.
|
Sep 18, 2019 10:59AM
|
|
Re: I like the chances for news
|
3
|
Resverlogix Corp.
|
Nov 08, 2015 08:55PM
|
